Eli Lilly released positive data from a test of a Covid-19 treatment, the second time in three days it’s posted positive data on a possible Covid-19 treatment, and Eli Lilly stock rose early.

The post Eli Lilly Posts Positive Data On Covid-19 Treatment In Phase 2 Trials appeared first on Investor's Business Daily.